Sign up to save your podcasts
Or
Share Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
497 Listeners
Neurology® Podcast
299 Listeners
Practical Neurology Podcast
50 Listeners
JAMA Neurology Author Interviews
12 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Neurology Exam Prep Podcast
188 Listeners
The Curious Clinicians
370 Listeners
The Lancet Neurology in conversation with
6 Listeners
Continuum Audio
81 Listeners